0.83 USD
▼-0.12-12.98%
盘后 0.88 0.00%
2026-11-20
市值
$10.88M
市盈率
—
EPS
-5.78
股息率
—
52 周区间
0.80 – 29.34
成交量
215.56K
Beta
2.89
目标价
23.80
52W 低 0.8052W 高 29.34
价格走势
公司简介
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably alteri...